Table 3.
The number of significant changes in dose for human-relevant concentration screening.
| 1MCF-7 (ER+) | 2MDA-MB-231 (ER−) | 3MCF-10A (normal) | ||||
|---|---|---|---|---|---|---|
| Açaí Extract | MTX | TAM | MTX | TAM | MTX | TAM |
| MRAQ 1 | 1 | 1 | - | - | - | - |
| MRAC | - | 1 | - | - | 1 | 1 |
| MRET | - | - | - | 1 | - | - |
| MRME* | - | - | 1 | - | 1 | - |
| F3AC 2,3 | - | - | 3 | 2 | 1 | 1 |
| F4AC 1,3 | 2 | 2 | - | 2 | 1 | - |
| F4ME 2 | - | 1 | 1 | 1 | - | - |
The numbers on the açaí extracts correspond to the cell line that was used for the future combinatorial assays. The asterisk (*) indicates the extract that was used in combination on all cell lines. The hyphen indicates no significant changes (p-values>0.05) in dose-response found in the combination.